Hooper, Stephen R.
Stephen R. Hooper researcher
VIAF ID: 5049220 (Personal)
Permalink: http://viaf.org/viaf/5049220
Preferred Forms
- 200 _ | ‡a Hooper ‡b Stephen R.
- 100 1 _ ‡a Hooper, Stephen R
-
-
-
- 100 1 0 ‡a Hooper, Stephen R.
- 100 1 _ ‡a Hooper, Stephen R.
-
- 100 1 _ ‡a Hooper, Stephen R.
-
-
-
-
- 100 0 _ ‡a Stephen R. Hooper ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study | |
Applicability of the nonverbal learning disability paradigm for children with 22q11.2 deletion syndrome | |
Assessment issues in child neuropsychology / ed. by Michael G. Tramontana and Stephen R. Hooper. - New York, 1988. | |
Assessment of parental disclosure of a 22q11.2 deletion syndrome diagnosis and implications for clinicians | |
Association of Blood Pressure Level With Left Ventricular Mass in Adolescents | |
Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome | |
Basics of child neuropsychology : a primer for educators and clinicians | |
Bicarbonate, blood pressure, and executive function in pediatric CKD-is there a link? | |
Blood pressure and school performance | |
The brain in pediatric chronic kidney disease-the intersection of cognition, neuroimaging, and clinical biomarkers | |
Characteristics of undiagnosed diseases network applicants: implications for referring providers | |
Child psychopathology : diagnostic criteria and clinical assessment | |
Cognitive improvement in children with CKD after transplant | |
Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome | |
Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference | |
Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. | |
Duration of chronic kidney disease reduces attention and executive function in pediatric patients | |
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes | |
Evaluation of Neurocognition in Youth with CKD Using a Novel Computerized Neurocognitive Battery | |
Frontal Hypoactivation During a Working Memory Task in Children With 22q11 Deletion Syndrome | |
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion | |
The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed disease | |
Genomic Disorders and Neurocognitive Impairment in Pediatric CKD. | |
Health Care Transition for Adolescents With CKD—The Journey From Pediatric to Adult Care | |
Health care transition preparation in youth with chronic conditions: working towards translational evidence with a patient perspective | |
Learning disability subtyping : neuropsychological foundations, conceptual models, and issues in clinical differentiation | |
Longitudinal Self-Management and/or Transition Readiness per the TRxANSITION Index among Patients with Chronic Conditions in Pediatric or Adult Care Settings | |
The nervous system and chronic kidney disease in children | |
Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy. | |
Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease | |
Neurological basis of childhood psychopathology | |
No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients. | |
Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders | |
Parental Communication and Experiences and Knowledge of Adolescent Siblings of Children with 22q11.2 Deletion Syndrome | |
Pediatric traumatic brain injury | |
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome | |
Psychosocial Profiles of Parents of Children with Undiagnosed Diseases: Managing Well or Just Managing? | |
The relationship of health care transition readiness to disease-related characteristics, psychosocial factors, and health care outcomes: preliminary findings in adolescents with chronic kidney disease | |
Self-Management and Transition Readiness Assessment: Concurrent, Predictive and Discriminant Validation of the STARx Questionnaire | |
SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth) | |
Sleep disordered breathing as measured by SRBD-PSQ and neurocognition in children with hypertension. | |
Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the intervention | |
Socioeconomic Status and Psychological Function in Children with Chromosome 22q11.2 Deletion Syndrome: Implications for Genetic Counseling | |
STRANDS manual : survey of teenage readiness and neurodevelopment status, administration, scoring, and interpretation | |
Subclinical Systolic and Diastolic Dysfunction Is Evident in Youth With Elevated Blood Pressure | |
Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study | |
Systematic review of structural and functional neuroimaging findings in children and adults with CKD. | |
A tale worth telling: the impact of the diagnosis experience on disclosure of genetic disorders. | |
Target Organ Abnormalities in Pediatric Hypertension | |
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome | |
A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network | |
Young children with special needs |